Cancer. Disseminated malignant neoplasm, unspecified
Conditions
Interventions
Intervention 1: The intervention group will use topical gel containing frankincense (10 percent) and honey twice daily for a week to ten days (the gel will be manufactured by Ariogen Sina Daru pharmac
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Informed consent Radiotherapy candidate patients in such a way that at least one third of the oral mucosa is included No history of head and neck radiotherapy
Exclusion criteria
Exclusion criteria: A history of frankincense allergy receiving concurrent chemotherapy regimen (other than cisplatin or cetuximab) Patients with liver problems Diabetes and history of hypoglycemia Patients with recurrent infections The presence of similar wounds in the genital area Joint swelling and pain, eye problems such as pain, blurriness and redness Using other drugs to treat the pest
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Zero, first, sixth and tenth days. Method of measurement: Using a visual pain scale.;Sense of taste. Timepoint: The zero and seventh days of study. Method of measurement: Using Patient Reported Outcome Measures (PROMS).;Ability to swallow solid and liquid substances. Timepoint: The zero and seventh days of study. Method of measurement: Using Patient Reported Outcome Measures (PROMS).;Speech disorder. Timepoint: The zero and seventh days of study. Method of measurement: Using Patient Reported Outcome Measures (PROMS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Seyed Shahram Miraghaei
Kermanshah University of Medical Sciences
Outcome results
None listed